R. Schmieder

1.7k total citations
59 papers, 1.3k citations indexed

About

R. Schmieder is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, R. Schmieder has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in R. Schmieder's work include Blood Pressure and Hypertension Studies (30 papers), Renin-Angiotensin System Studies (12 papers) and Hormonal Regulation and Hypertension (9 papers). R. Schmieder is often cited by papers focused on Blood Pressure and Hypertension Studies (30 papers), Renin-Angiotensin System Studies (12 papers) and Hormonal Regulation and Hypertension (9 papers). R. Schmieder collaborates with scholars based in Germany, Spain and United Kingdom. R. Schmieder's co-authors include Markus P. Schlaich, Christian Delles, Arnfried U. Klingbeil, Markus P. Schneider, F H Messerli, Stefan John, Peter Martus, Michael Gekle, Walter Zidek and Michel Azizi and has published in prestigious journals such as The Lancet, JAMA and Journal of the American Society of Nephrology.

In The Last Decade

R. Schmieder

56 papers receiving 1.2k citations

Peers

R. Schmieder
F H Messerli United States
Enrico Agabiti Rosei Italy
Christian Ott Germany
Klaus O. Stumpe Germany
Andrej Dukát Slovakia
Giovanni Cerasola Italy
C. Dal Palú Italy
Osamu Hirashima Japan
Nobutaka Hirai Japan
Domenico Galzerano Italy
F H Messerli United States
R. Schmieder
Citations per year, relative to R. Schmieder R. Schmieder (= 1×) peers F H Messerli

Countries citing papers authored by R. Schmieder

Since Specialization
Citations

This map shows the geographic impact of R. Schmieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Schmieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Schmieder more than expected).

Fields of papers citing papers by R. Schmieder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Schmieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Schmieder. The network helps show where R. Schmieder may publish in the future.

Co-authorship network of co-authors of R. Schmieder

This figure shows the co-authorship network connecting the top 25 collaborators of R. Schmieder. A scholar is included among the top collaborators of R. Schmieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Schmieder. R. Schmieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmieder, R.. (2015). Glomerular Hyperfiltration in Essential Hypertension: Cause or Consequence?. Contributions to nephrology. 119. 91–97.
2.
Mahfoud, Felix, Christian Ukena, & R. Schmieder. (2013). Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients with Resistant Hypertension. Journal of Vascular Surgery. 58(5). 1424–1424. 4 indexed citations
3.
Schmieder, R., Luís M. Ruilope, Christian Ott, Felix Mahfoud, & Michael Böhm. (2013). Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring. Journal of Human Hypertension. 27(12). 715–720. 16 indexed citations
4.
Raff, Ulrike, Claus‐Eric Ott, Stefan John, et al.. (2010). Nitric Oxide and Reactive Hyperemia: Role of Location and Duration of Ischemia. American Journal of Hypertension. 23(8). 865–869. 18 indexed citations
5.
Ritt, Marco J.P.F., Rolf Janka, Markus P. Schneider, et al.. (2009). Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrology Dialysis Transplantation. 25(4). 1126–1133. 67 indexed citations
6.
Pauschinger, M., et al.. (2009). Erhaltene systolische Funktion und doch herzinsuffizient?. MMW - Fortschritte der Medizin. 151(23). 41–43. 5 indexed citations
7.
Delles, Christian, et al.. (2008). Effects of Telmisartan and Ramipril on Adiponectin and Blood Pressure in Patients with Type 2 Diabetes. American Journal of Hypertension. 21(12). 1330–1336. 26 indexed citations
8.
Schmieder, R. & F H Messerli. (2008). Compliance großer elastischer Arterien nach blutdrucksenkender Therapie mit einem Calciumantagonisten. DMW - Deutsche Medizinische Wochenschrift. 120(25/26). 907–911. 1 indexed citations
9.
Silber, Sigmund, et al.. (2007). Der Patient mit arterieller Hypertonie in der kardiologischen Facharztpraxis: Ergebnisse des Snapshot-Hypertonie-Registers. DMW - Deutsche Medizinische Wochenschrift. 132(46). 2430–2435. 7 indexed citations
10.
Schwarz, T., et al.. (2007). Left-Ventricular Structure and Function Are Influenced by Angiotensinogen Gene Polymorphism (−20 A/C) in Young Male Patients. American Journal of Hypertension. 20(9). 974–980. 7 indexed citations
11.
Pool, James L., R. Schmieder, Michel Azizi, et al.. (2006). Aliskiren, an Orally Effective Renin Inhibitor, Provides Antihypertensive Efficacy Alone and in Combination With Valsartan. American Journal of Hypertension. 20(1). 11–20. 180 indexed citations
12.
Schmieder, R.. (2005). Mechanisms for the Clinical Benefits of Angiotensin II Receptor Blockers. American Journal of Hypertension. 18(5). 720–730. 108 indexed citations
13.
John, Stefan, et al.. (2004). The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men. American Journal of Hypertension. 17(12). 1120–1126. 2 indexed citations
14.
Delles, Christian, et al.. (2002). Assessment of endothelial function of the renal vasculature in human subjects. American Journal of Hypertension. 15(1). 3–9. 29 indexed citations
15.
Klingbeil, Arnfried U., et al.. (2000). Enhanced antinatriuresis in response to angiotensin II in essential hypertension. American Journal of Hypertension. 13(9). 986–993. 7 indexed citations
16.
Schmieder, R. & F H Messerli. (2000). Hypertension and the heart. Journal of Human Hypertension. 14(10-11). 597–604. 81 indexed citations
17.
Schmieder, R., Markus P. Schlaich, Arnfried U. Klingbeil, & Peter Martus. (1998). Meta-analysis. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrology Dialysis Transplantation. 13(3). 564–569. 145 indexed citations
18.
Schlaich, Markus P. & R. Schmieder. (1998). Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approachFocus on treatment by antihypertensive agents. American Journal of Hypertension. 11(11). 1394–1404. 55 indexed citations
19.
Veelken, Roland, Karl F. Hilgers, Karie E. Scrogin, Johannes F.E. Mann, & R. Schmieder. (1998). Endogenous angiotensin II and the reflex response to stimulation of cardiopulmonary serotonin 5HT3 receptors. British Journal of Pharmacology. 125(8). 1761–1767. 16 indexed citations
20.
Veelken, Roland & R. Schmieder. (1996). Overview of α1-Adrenoceptor Antagonism and Recent Advances in Hypertensive Therapy. American Journal of Hypertension. 9(11). 139S–149S. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F H Messerli Breakdown of academic impact, for papers by Enrico Agabiti Rosei Breakdown of academic impact, for papers by Christian Ott Breakdown of academic impact, for papers by Klaus O. Stumpe Breakdown of academic impact, for papers by Andrej Dukát Breakdown of academic impact, for papers by Giovanni Cerasola Breakdown of academic impact, for papers by C. Dal Palú Breakdown of academic impact, for papers by Osamu Hirashima Breakdown of academic impact, for papers by Nobutaka Hirai Breakdown of academic impact, for papers by Domenico Galzerano
Rankless by CCL
2026